Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SeaStar Medical Holding (ICU) EBIT Margin (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed EBIT Margin for 3 consecutive years, with 1956.83% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBIT Margin rose 459611.0% year-over-year to 1956.83%, compared with a TTM value of 1640.28% through Sep 2025, down 1405269.0%, and an annual FY2024 reading of 13216.3%, changed N/A over the prior year.
  • EBIT Margin was 1956.83% for Q3 2025 at SeaStar Medical Holding, down from 519.53% in the prior quarter.
  • Across five years, EBIT Margin topped out at 1666.67% in Q2 2023 and bottomed at 13620.0% in Q4 2024.
  • Average EBIT Margin over 3 years is 2467.28%, with a median of 911.98% recorded in 2025.
  • The sharpest move saw EBIT Margin plummeted -1511086bps in 2024, then surged 459611bps in 2025.
  • Year by year, EBIT Margin stood at 1490.86% in 2023, then plummeted by -1014bps to 13620.0% in 2024, then skyrocketed by 86bps to 1956.83% in 2025.
  • Business Quant data shows EBIT Margin for ICU at 1956.83% in Q3 2025, 519.53% in Q2 2025, and 1304.44% in Q1 2025.